SR 43845: RN given refers to (S-(R*,R*))-isomer; RN for cpd without isomeric designation not available 8/89 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 163918 |
| MeSH ID | M0168061 |
| Synonym |
|---|
| sr 43845 |
| 2-[[5-cyclohexyl-3-hydroxy-4-[[3-(1h-imidazol-5-yl)-2-[[3-phenyl-2-(3-pyridin-3-ylpropanoylamino)propanoyl]amino]propanoyl]amino]pentanoyl]amino]-n-(1,3-dihydroxy-2-methylpropan-2-yl)-3-methylpentanamide |
| sr-43845 |
| l-threo-pentonamide, 5-cyclohexyl-2,4,5-trideoxy-n-(1-(((2-hydroxy-1-(hydroxymethyl)-1-methylethyl)amino)carbonyl)-2-methylbutyl)-4-((n-(n-(1-oxo-3-(3-pyridinyl)propyl)-l-phenylalanyl)-l-histidyl)amino)-, (s-(r*,r*))- |
| 114037-60-4 |
| AKOS040747506 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.09) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||